Related Experiment Videos
Performance status assessment in cancer patients
C Conill1, E Verger, M Salamero
1Department of Radiotherapy, Hospital Clinic i Provincial, Barcelona, Spain.
Cancer
|April 15, 1990
Summary
Patient self-assessment of performance status using Karnofsky performance status (KPS) and Eastern Cooperative Oncology Group (ECOG) scales is reliable. Patient evaluations show significant correlation with physician assessments, suggesting their value in clinical practice.
Area of Science:
- Oncology
- Clinical Assessment
- Biostatistics
Background:
- Performance status assessment is crucial in oncology for treatment decisions and prognosis.
- Karnofsky performance status (KPS) and Eastern Cooperative Oncology Group (ECOG) are widely used scales.
- Evaluating the reliability and validity of these scales, especially patient self-assessment, is important for clinical utility.
Purpose of the Study:
- To assess the validity and reliability of Karnofsky performance status (KPS) and Eastern Cooperative Oncology Group (ECOG) scales.
- To compare physician assessments with patient self-assessments.
- To determine if patient self-evaluation offers a valuable and reliable performance status assessment.
Main Methods:
- 100 consecutive cancer patients participated in the study.
- Performance status was assessed independently by two physicians and by the patients themselves using KPS and ECOG scales.
- Kendall's correlation coefficient was used to analyze the agreement between assessments.
Main Results:
- High inter-physician reliability was found for both KPS (0.76) and ECOG (0.75).
- Significant correlations were observed between physician and patient assessments for KPS (0.65) and ECOG (0.59).
- Patient self-assessments demonstrated considerable agreement with physician evaluations.
Conclusions:
- Both KPS and ECOG scales demonstrate good reliability when used by physicians.
- Patient self-assessment of performance status using KPS and ECOG scales is a reliable and valid method.
- Patient self-evaluation can be a valuable addition to performance status assessment in clinical oncology.